![](/img/cover-not-exists.png)
Combination of an ASK1 inhibitor and FXR agonist increases efficacy in a mouse model of non-alcoholic steatohepatitis
Liles, J.T., Zagorska, A., Hollenback, D., Budas, G.R., Liu, H., Liu, K., Brockett, R., Shauf, A., Tumas, D., Breckenridge, D.G.Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(17)30301-X
File:
PDF, 68 KB
english, 2017